Cytodyn just settled their board lawsuit. It was one of their bigger sticking points to unwind.

This settlement added with a mild Board reorganization by the agreement that limits ability to redo the unauthorized share distribution makes for a stronger company going forward and less of a angle of attack that the board is tilted towards NP

https://news.bloomberglaw.com/pharma-and-life...-comp-case